Partner guy tsjoen
Benita Arren was the third person to join an innovative study of transgender individuals in Belgium. Credit: Bea Uhart. Benita Arren wishes that the human body came with instructions. About a decade ago, Arren was struggling with inner conflict. Then in her forties, married with two children and busy with a job in Antwerp, Belgium, she found them resurfacing.SEE VIDEO BY TOPIC: winners Ypres Rally 2017 Kevin Abbring Pieter Tsjoen
SEE VIDEO BY TOPIC: WELCOME TO THE AA EPISODE #16 AYCO DUYSTERContent:
- Meet Professor Guy T’Sjoen, transgender health specialist and ECE speaker
- The largest study involving transgender people is providing long-sought insights about their health
- Transsexuality – Medical possibilities and social attitudes
- Welcome To The AA
- Decisions made at IAAF Council Meetings in Doha
- Sexual and Physical Health After Sex Reassignment Surgery
- Mother and daughter became father and son: a case report.
- Academic Bibliography
Meet Professor Guy T’Sjoen, transgender health specialist and ECE speaker
He is particularly interested in transgender health, and will be presenting at a Meet the Expert session on the effects of hormone therapy on bone in transgender persons at ECE We interviewed him to find out more about his career, transgender research and what he is looking forward to at ECE During my training as an endocrinologist, I met a transgender woman and had the opportunity to talk to her.
She told me her life story: how she came out, how she started hormone treatment, what happened with surgery, how her family reacted and how she managed at work. I was so impressed by her story that I started researching the endocrine literature on what hormone treatments were available for transgender people, and found that there were very few publications.
Those available were from the Free University of Amsterdam, so I contacted them and I went there as an observer for a couple of weeks.
On my return, I began organising transgender care into our research programme, and I have been doing that ever since. My PhD was on transgender care, and since then I have published over papers on the topic. I also founded the endocrine part of the European Network for the Investigation of Gender Incongruence ENIGI , and we have been collaborating at a European level to gather data on hormone therapy and transgender care.
Although the available data is limited on the long-term effects, we know that in the short-term transgender men female to male have good bone density. However, a substantial portion of transgender women male to female have already developed osteoporosis before any hormone intervention has taken place, which may be related to lifestyle factors, such as low physical activity levels, low vitamin D status, and more social isolation. The good news is that the oestrogen hormone treatment is beneficial for bone density, so their bone health will usually improve.
This highlights how endocrinology is a very broad field, involving a lot of different organs and hormones.
As a scientist, I find it very challenging not to focus on one very specific niche, so I am very pleased to have a poster on a topic other than transgender science.
What are you looking forward to at ECE and what would you recommend to others? As an andrologist, I am looking forward to Symposium 9 on male gonadal function versus general health, which is a joint session organised by ESE and the European Society of Andrology.
I have talked about andrology on Belgian TV quite often and recently published a book aimed at the general public on andrology-related health. I think it is very important for scientists to step out of their ivory towers and to engage the public and provide them with the information they need or want on andrology. This symposium is of particular interest as it unites two specialities that I belong in, endo- and andro-, and it is important to stay up-to-date with the most recent research.
Most research on transgender people including the psychological, endocrinology and surgical research comes from Europe. So, I thought it was very relevant to create an organisation specifically for professionals in this field in Europe.
The number of transgender people attending endocrine clinics is increasing, so there is an increasing need for up-to-date and relevant information for professionals working in this field. In the beginning, EPATH had no funds, so using sponsorship from the local university and from colleagues and friends we were able to organise the first conference in Last year it was in Belgrade, Serbia, and again we sold out really quickly.
We hope to hold the event throughout Europe in the coming years. There is a lack of good long-term research in transgender science. Most research studies are cross-sectional studies on Western-European populations. No single centre, except for Ghent and Amsterdam, has a sufficiently large patient base to be able to study outcomes with any statistical rigor, and if they do the time spent in patient care conflicts with performing research projects.
There is also a lack of education on transgender patient care for health care professionals. An improvement of formal transgender health education in medical schools and among health care providers is needed.
Transgender health care should also be included at national and international conferences of all related specialties. More patient-centred research will lead to better studies and transgender community involvement will be crucial to identify research priorities, aid research design, help with recruitment and dissemination of study results. Transgender medicine research is finally moving away from case reports and small series.
Clinicians and academics must listen to the voices of transgender people, recognising and respecting the internal diversity within the transgender community, to improve patient care and outcomes. There will be larger cohorts for studies.
When I started there was only limited, local information and the hormonal protocols greatly varied. Some publications had just 17 or 20 participants, now we are getting to over However, compared to other endocrine research topics, these numbers are still tiny.
I strongly believe that we should invest much more in European networks, to get more people involved, and also very importantly, make sure that people read and understand the available research to avoid unnecessary repetition. This will lead to better research and ultimately advances in the field.
Do you have any words of wisdom for aspiring endocrinologists attending ECE ? I think the most important thing is to be prepared. I remember when I was a young endocrinologist myself and went to conferences — by the time I knew what and where the sessions were I had already missed half of them. Everybody likes to be talked to and acknowledged, and maybe you will spark a new collaboration. That is something that has worked for me in the past. There were some people working in transgender science, so I went to see their poster and really talked to them and now some of those people are my collaborators.
When I was a young endocrinologist, there was a Danish endocrinologist who I heard speaking at a conference, Claus Gravholt; he specialised in Turner syndrome, a topic very few endocrinologists were interested in. The fact that he focused his attention on a patient group that had been ignored for such a very long time, and the enthusiasm he showed while presenting, was something that really motivated me.
He did the same with Klinefelter syndrome, and I believe it is greatly due to him that both Turner and Klinefelter syndromes now feature with increased importance during endocrine training, and this has had a tremendous impact for patients.
This colleague conducted beautiful research of high quality and had a lot of enthusiasm — he still does, in fact, and it is very addictive. This is very unusual for a doctor. The consultations are open discussions, where people express their needs and then as a doctor, based upon your knowledge, you try to be creative. This is especially true for a group which is becoming more visible now, the gender non-binary people, or those who consider themselves to be neither male nor female.
What have been your proudest professional experiences so far? What do you think are the biggest challenges in your research area right now? What do you think will be the next major advances in transgender science?
The largest study involving transgender people is providing long-sought insights about their health
Net zoals vorige keer is het een gezellig en chaotisch weerzien met de handigste man van Vlaanderen. In de reality-reeks Twee tinten grijs die vanaf dinsdag 28 april op EEN start, onderzoeken Pascal Braeckman , de bekendste klankman van Europa, en Jan Van Eyken , gitarist bij de Kreuners , acht weken lang hoe hun leven eruit kan zien na hun pensioen. Sterker zelfs, moeten we daar in de eerste plaats al onze privacy voor opgeven? Ook deze week bellen we weer een bekend gezicht op en ditmaal is dat privacy specialist en allround fijne vent Matthias Dobbelaere-Welvaert die op al deze vragen een antwoord komt geven.
A long-term follow-up study of 55 transsexual patients 32 male-to-female and 23 female-to-male post-sex reassignment surgery SRS was carried out to evaluate sexual and general health outcome. Relatively few and minor morbidities were observed in our group of patients, and they were mostly reversible with appropriate treatment. A trend toward more general health problems in male-to-females was seen, possibly explained by older age and smoking habits. Although all male-to-females, treated with estrogens continuously, had total testosterone levels within the normal female range because of estrogen effects on sex hormone binding globulin, only
Transsexuality – Medical possibilities and social attitudes
Gender-affirming treatment of transgender people requires a multidisciplinary approach in which endocrinologists play a crucial role. The aim of this paper is to review recent data on hormonal treatment of this population and its effect on physical, psychological, and mental health. The Endocrine Society guidelines for transgender women include estrogens in combination with androgen-lowering medications. Feminizing treatment with estrogens and antiandrogens has desired physical changes, such as enhanced breast growth, reduction of facial and body hair growth, and fat redistribution in a female pattern. Possible side effects should be discussed with patients, particularly those at risk for venous thromboembolism. The Endocrine Society guidelines for transgender men include testosterone therapy for virilization with deepening of the voice, cessation of menses, and increases of muscle mass and facial and body hair. Owing to the lack of evidence, treatment of gender nonbinary people should be individualized. Young people may receive pubertal suspension, consisting of GnRH analogs, later followed by sex steroids. Options for fertility preservation should be discussed before any hormonal intervention. Morbidity and cardiovascular risk with cross-sex hormones is unchanged among transgender men and unclear among transgender women.
Welcome To The AA
Lead Sponsor. University Hospital, Ghent. Has Dmc. The physical and psychological effects of the hormonal treatment of transsexual persons are not sufficiently described. The low prevalence of transsexualism was the stimulus to search for European partners for this Protocol.
Decisions made at IAAF Council Meetings in Doha
To browse Academia. Skip to main content. Log In Sign Up. Katrien Wierckx. Eva Van Caenegem. Transgenderism and reproduction.
Sexual and Physical Health After Sex Reassignment Surgery
He is particularly interested in transgender health, and will be presenting at a Meet the Expert session on the effects of hormone therapy on bone in transgender persons at ECE We interviewed him to find out more about his career, transgender research and what he is looking forward to at ECE During my training as an endocrinologist, I met a transgender woman and had the opportunity to talk to her. She told me her life story: how she came out, how she started hormone treatment, what happened with surgery, how her family reacted and how she managed at work. I was so impressed by her story that I started researching the endocrine literature on what hormone treatments were available for transgender people, and found that there were very few publications. Those available were from the Free University of Amsterdam, so I contacted them and I went there as an observer for a couple of weeks. On my return, I began organising transgender care into our research programme, and I have been doing that ever since.
The Council approved the principles of a new marketing and advertising approach, devised in agreement with Dentsu. New regulations will be presented to the Council for approval in November. For marketing and advertising on clothing it is proposed to:. The Council approved the Eligibility Regulations for Transgender Athletes which now replace the former Sex Reassignment Regulations introduced in
Mother and daughter became father and son: a case report.
A blood sample is taken for sex steroid analysis. The relation will be investigated between testosteron, free testosteron, sex hormone binding globulin, estradiol, DHEA and androstenedion and scores on relational and sexual satisfaction and sexual desire. Latest version submitted December 19, on ClinicalTrials.
Search publications Advanced search. Downloads Download. Transgenderism and reproduction.
Nein, - солгал немец. - Я не. Я сейчас же отправлю ее домой. - Боюсь, вы опоздали, - внушительно заявил Беккер и прошелся по номеру.
Девушка с сумкой была уже на улице. - Меган! - завопил он, грохнувшись на пол. Острые раскаленные иглы впились в глазницы. Он уже ничего не видел и только чувствовал, как тошнотворный комок подкатил к горлу. Его крик эхом отозвался в черноте, застилавшей.
Беккер не знал, сколько времени пролежал, пока над ним вновь не возникли лампы дневного света.
Среднее время, потраченное на один шифр, - чуть более шести минут. Потребление энергии на среднем уровне. Последний шифр, введенный в ТРАНСТЕКСТ… - Она замолчала. - Что .